Osteoporosis
From the Journals
Eldecalcitol may increase bone mineral density in poor responders to bisphosphonates
Among patients with osteoporosis who have diminished long-term response to bisphosphonate therapy, eldecalcitol reduces bone turnover markers.
From the Journals
Osteoporosis, osteoarthritis risk high among cerebral palsy patients
This is the first study to compare these risks using a relatively large cohort of adults with and without cerebral palsy.
From the Journals
Once-weekly teriparatide still achieves bone mineral density gains
From the Journals
Osteoporotic fracture risk appears higher in adults with hemophilia
The risk of osteoporotic fractures following hemophilia increased with time and was significantly higher 5 years after the diagnosis.
Video
Bisphosphonates before denosumab may prevent postdenosumab BMD rebound effect
MADRID – Preliminary results suggest that using denosumab after bisphosphonates for rebound is effective and monitoring bone turnover markers at...
From the Journals
Consider drug treatment in late-life women with osteoporosis
The 5-year risk of hip fracture is high in women aged 80 years or older with osteoporosis.
App Review
An app to help women and clinicians manage menopausal symptoms
This menopause app facilitates personalized treatment decisions
In North America, women experience menopause (the permanent cessation of...
From the Journals
Younger men and women show similar rates of osteopenia
A new study finds that about a quarter of both men and women in early middle age have osteopenia in at least one site.
Commentary
More empathy for women
Dr. Carl C. Bell says the antitestosterone hormones he is taking are changing his perspective.
Conference Coverage
Emerging data support anabolic-first regimens for severe osteoporosis
LOS ANGELES –
From the Journals
Knowledge gaps about long-term osteoporosis drug therapy benefits, risks remain large
A position paper makes recommendations based on findings from an NIH workshop and systematic review.